Transient Aggregation-Prone States in Disordered Proteins as Therapeutic Targets: The Amyloid-β Case
Open Access
- 15 April 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (11) , 6591-6601
Abstract
The amyloid-β (Aβ) peptide is an intrinsically disordered protein whose self-association into toxic oligomers underlies Alzheimer's disease. Because of its dynamic and heterogeneous nature, identifying the conformational states that nucleate aggregation remains a central challenge. In this work, we introduce a chemically interpretable descriptor of amyloidogenic propensity derived from self-docking analyses of conformational ensembles generated through temperature-replica exchange molecular dynamics (T-REMD) using different and complementary force fields. This descriptor classifies individual conformers within the generated ensembles according to their intrinsic aggregation tendency, enabling the identification of metastable, aggregation-prone states. The resulting ensembles reproduce experimental observables, and their classification based on amyloidogenic propensity provides a consistent structural basis for the rationalization and study of these metastable conformers. As a test, we demonstrate that the molecular chaperone DNAJB6, experimentally known to bind amyloidogenic conformations, preferentially interacts with aggregation-prone conformers, thus supporting both the proposed protocol and the consistency of the classification scheme. More broadly, this framework outlines a potentially generalizable strategy to identify metastable states in intrinsically disordered proteins as prospective pharmacological targets to help develop drugs or biomolecules capable of inhibiting the early stages of their aggregation.Keywords
Funding Information
- NextGenerationEU (ECS 00000017)
This publication has 51 references indexed in Scilit:
- Morphological inhibitors of aggregation-prone amyloid-
β
conformers: A computational explorationComputers in Biology and Medicine, 2025
- Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s DiseaseBioDrugs, 2023
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic reviewAgeing Research Reviews, 2021
- Replica Exchange Molecular Dynamics: A Practical Application Protocol with Solutions to Common Problems and a Peptide Aggregation and Self-Assembly Example2018
- Highly Disordered Amyloid-β Monomer Probed by Single-Molecule FRET and MD SimulationBiophysical Journal, 2018
- Role of β-Hairpin Formation in Aggregation: The Self-Assembly of the Amyloid-β(25–35) PeptideBiophysical Journal, 2012
- Characterizing amyloid‐beta protein misfolding from molecular dynamics simulations with explicit waterJournal of Computational Chemistry, 2010
- Peptide Folding: When Simulation Meets ExperimentAngewandte Chemie International Edition, 1999
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996